Smith & Nephew Plc

LONDON, August 5, 2011 - Medical devices group Smith & Nephew reports sales growth of 12% and underlying sales growth of 5%.

HULL, England and FT. SASKATCHEWAN, Canada, December 22 - The Advanced Wound Management division of Smith & Nephew plc (LSE: SN; NYSE: SNN), announced today that its affiliates have completed the acquisition of substantially all of the assets of Nucryst Pharmaceuticals Corp.